Orit Markowitz, M.D., F.A.A.D.

5 East 98th Street5th Floor

New York, NY 10029

347-881-3392

info@oritmarkowitzmd.com
  

CLINICAL PRACTICE

Mount Sinai Faculty Practice, New York, NY

2007 - Present               Director, Pigmented Lesions & Skin Cancer

ACADEMIC & HOSPITAL APPOINTMENTS

Mount Sinai School of Medicine, New York, NY

2017 – Present              Associate Professor, Department of Dermatology

2009 - 2017                  Assistant Professor, Department of Dermatology

Downstate Medical Center, Brooklyn, NY

2009 - Present               Adjunct Associate Professor, Department of Dermatology

Mount Sinai Medical Center, Queens General, Jamaica, NY

2009 - Present               Chief, Department of Dermatology

Brooklyn Veterans Hospital, Brooklyn, NY

2007 - Present               Director, Pigmented Lesions Clinic

Mount Sinai School of Medicine, New York, NY

2011 - Present               Co-Director, Imaging Research Fellowship, Department of Dermatology

Mount Sinai School of Medicine, New York, NY

2007 - 2009                  Clinical Instructor, Department of Dermatology

Tisch Hospital, NYU Medical Center, New York, NY

2007 - 2008                  Clinical Instructor, Skin & Cancer Unit CLINICAL TRAINING

Downstate University Medical Center, Brooklyn, NY

2004 - 2007                  Resident, S.U.N.Y. Downstate Department of Dermatology

LIJ/North Shore University Hospital, New Hyde Park, NY

2003 – 2004                 Intern, Department of Medicine

EDUCATION

2003                            MD, Drexel University College of Medicine, Philadelphia, PA

1997                            Post Baccalaureate, Tufts University, Medford, MA

1996                            Brandeis University, Waltham, MA - BA, Cum Laude, Psychology

 

MEDICAL SOCIETIES

2011 - Present   President, International Optical Coherence Tomography Society

2011 - Present   Women’s Dermatologic Society

2010 - Present   International Dermoscopy Society

2009 - Present   International Confocal Society

2007 - Present   American Medical Association

2007 - Present   Medical Society of the State of New York

2007 - Present   Fellow, American Academy of Dermatology

 

COMMITTEE MEMBERSHIPS

2017 – present              AAD In-Vivo Microscopy of the Skin Work Group

2017 – present              AAD Member of the Council on Community, Corporate & Philanthropic Relations

2012 - 2015                  AAD Melanoma Committee

2012 - 2015                  AAD International Women’s Dermatologic Society Committee

 

EDITORIAL BOARD MEMBERSHIPS

2016 – Present  Cutis

2016- Present   Journal of Cosmetic and Aesthetic Dermatology

2011 - Present   Skin Health News Letter

 

AWARDS

2018                            Melanoma Research Foundation Humanitarian Award

2010 - 2011                  Mount Sinai School of Medicine Clinical Excellence Teaching Award

 

GRANTS AND CLINICAL TRIALS

ACTIVE

Role: Co-Principal Investigator with Dr. Daniel Siegel

Title: Field Cancerization: A prospective observational study using hand-held confocal microscopy and optical coherence tomography (OCT) in Levulan Kerastick (aminolevulinic acid and HCl) and Blue light treated patients.

Study Site: Brooklyn Veterans Affair Hospital New York Harbor Healthcare System

Study Sponsor: DUSA Pharmaceuticals

 

Role: Co-Principal Investigator with Dr. Daniel Siegel

Title: Monitoring Distal Lateral Subungual Onychomycosis Clearance with Efinaconazole Topical Solution Using Non-invasive Optical Coherence Tomography at Specific Time Intervals

Study Site: Multicenter at Mount Sinai Hospital and Brooklyn Veterans Affair Hospital

Study Sponsor: Valeant Pharmaceuticals North America

 

Role: Co-Principal Investigator with Dr. Daniel Siegel

Title: “Secukinumab therapy for the treatment of moderate to severe plaque psoriasis with response monitoring using optical coherence tomography”

Study Site: Brooklyn Veterans Affair Hospital

Investigator Initiated Trial: Novartis Pharmaceuticals

 

Role: Principal Investigator

Title: “A randomized, double-blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-211 ALA (Ameluz) and BF-RhodoLed in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT)”

Study Site: Brooklyn Veterans Affair Hospital New York Harbor Healthcare System

Study Sponsor: Biofrontera

 

Role: Principal Investigator

Title: “Real-time imaging of skin in peanut-allergic patients undergoing epicutaneous treatment Viaskin Peanut using non-invasive reflectance confocal microscopy”

Study Site: Mount Sinai Hospital

Investigator Initiated Trial: DBV Technologies

 

Role: Principal Investigator

Title: “Monitoring nail changes in patients with psoriatic disease treated with etanercept using non-invasive optical coherence tomography”

Study Site: Brooklyn Veterans Affair Hospital New York Harbor Healthcare System

Investigator Initiated Trial: Amgen

 

Role: Principal Investigator

Title: “Monitoring response to therapy in atopic dermatitis patients treated with dupilumab using non-invasive reflectance confocal microscopy and optical coherence tomography”

Study Site: Brooklyn Veterans Affair Hospital New York Harbor Healthcare System

Investigator Initiated Trial: Regeneron

 

Role: Principal Investigator

Title: “Diagnosing and monitoring treatment of actinic keratoses treated with ingenol mebutate 0.015% in patients £ 50 years of age using optical coherence tomography and reflectance confocal microscopy”

Study Site: Mount Sinai Hospital

Investigator Initiated Trial: LEO Pharma Inc.

 

PUBLICATIONS PEER REVIEWED JOURNALS

Markowitz O, Psomadakis C. Patient-driven management: same-day non-invasive diagnosis and complete laser treatment of basal cell carcinomas, a pilot study. Cutis. 2019. Publication status: Accepted August 2019. 

Tongdee E, Psomadakis C, Paka P, Marghoob N, Markowitz O. Emerging non-invasive treatments of non-melanoma skin cancers: 2018 and beyond. Cutis. 2019. Accepted.

Tongdee E, Psomadakis C, Paka P, Marghoob N, Markowitz O. Advanced squamous cell carcinoma – what’s new?. Current Dermatology Reports. 2019. Accepted.

Markowitz O, Tongdee E, Levine A. Optimal cosmetic outcomes for basal cell carcinomas: a retrospective review of non-ablative laser management. Cutis. May 2019. Accepted.

Marghoob N, Psomadakis C, Markowitz O. Noninvasive imaging to improve diagnostic accuracy: a case report. JAAD Case Reports. Accepted.

Tongdee E, Siegel D, Markowitz O. New diagnostic procedure codes and reimbursement. Cutis. 2019 April;103(04)208-211.

Tongdee E, Markowitz O. Mobile app rankings in dermatology. Cutis. 2018 October;102(4):252-256.

Levine A, Markowitz O. Introduction to Reflectance Confocal Microscopy and its use in Clinical Practice. JAAD Case Reports. 2018. Submitted.

Bleicher B, Levine A, Markowitz O. Going Digital With Dermoscopy. Cutis. 2018 August; 102(2):102-105.

Levine A, Bleicher B, Markowitz O, Siegel DM. Commentary on Swept-Source Optical Coherence Tomography-Supervised Biopsy. Dermatologic Surgery. 2018 Jun;44(6):776-777.

Levine A, Siegel DM, Markowitz O. Update on non-invasive diagnostic imaging and management of non-melanoma skin cancer. Current Dermatology Reports (2018), 7:1-15.

Levine A, Markowitz O. Other Technologies in Skin Cancer Diagnosis. Cancer of the Skin – 3rd edition. Submitted November 2017.

Fisher J, Siegel D, Markowitz O. Clinical utility of bedside multibeam optical coherence tomography imaging in a patient with multiple basal cell carcinomas. Dermatologic Surgery, December 2017 – eprint.

Levine A, Siegel D, Markowitz O. Imaging in cutaneous surgery. Future Oncology. November 2017;13(26):2329-2340. Doi: 10.2217/fon-2017-0277. PMID 29121782

Bleicher B, Levine A, Schwartz M, Markowitz O.  A review through the looking glass: new advances in dermoscopy, Giornale Italiano di Dermatologie e Venereologia. September 2017. doi: 10.23736/S0392-0488.17.05777-7. Accepted, epub.

Schwartz M, Levine A, Markowitz O.  Optical Coherence Tomography in Dermatology. Cutis. 2017 September; 100(3):163-166

Winkelmann RR, Farberg AS, Glazer AM, Cockerell CJ, Sober AJ, Siegel DM, Leachman SA, High WA, Markowitz O, Berman B, Pariser DM, Goldenberg G, Rosen T, Rigel DS.  Integrating Skin Cancer-Related Technologies into Clinical Practice.  Dermatol Clin. 2017 Oct;35(4):565-576.

Levine A, Wang K, Markowitz O. Optical Coherence Tomography in the diagnosis of skin cancer. Dermatologic Clinics. 2017 Oct;35(4):465-488.

Levine A, Markowitz O. In Vivo Reflectance Confocal Microscopy. Cutis. 2017 June; 99(6):399-402.

Markowitz O, Wang K, Levine A, Schwartz M, Minhas S, Feldman E, Siegel D. Noninvasive long-term monitoring of actinic keratosis and field cancerization following treatment with ingenol mebutate gel 0.015%. J Clin Aesthet Dermatol.  Accepted May 2017

Markowitz O. First Opinion: “I can’t always play it safe with my patients. That’s why I cautiously innovate”. STAT News. March 2017.

Levine A., Markowitz O. Update on advanced basal cell carcinoma diagnosis and treatment. Dermatology Times. 2016 November. Volume 38.

Levine A., Wang K., Markowitz O. Optical Coherence Tomography for Skin Cancer Screening. Gavin Journal of Dermatology Research and Therapy. 2016 August. 24-25.

Schwartz M., Minhas S., Kalowitz BA, Meekings A., Markowitz O. The Use of Non-Invasive Optical Coherence Tomography to Monitor the Treatment Progress of Vismodegib and Imiquimod 5% Cream in a Transplant Patient with Advanced Basal Cell Carcinoma of the Nose. CCID. 2016 August.

Schwartz M., Siegel DM., Markowitz O. Commentary on the Diagnostic Utility of Non-Invasive Imaging Devices for Field Cancerization. Experimental Dermatology. 2016 June.

Markowitz O., Schwartz M., Feldman E., Bieber A., Bienenfeld A., Nandanan N., Siegel DM. Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%–Treated Patients. JCAD. 2016 May; 9(5):18-25.

Emilio J., Schwartz M., Feldman E., Bieber AK., Bienenfeld A., Jung MK., Siegel DM., Markowitz O. Improved Patient Satisfaction Using Ingenol Mebutate Gel 0.015% for the Treatment of Facial Actinic Keratoses: A Prospective, Preplanned Pilot Study. Clin Cosmet Investig Dermatol. 2016 April; 9: 89-93. 

Meekings A., Utz S., Ulrich M., Bienenfeld A., Nandanan N., Fischer J., McKenzie G., Siegel D., Markowitz O. Differentiation of Basal Cell Carcinoma Subtype in Multi-Beam Swept Source Optical Coherence Tomography (MSS-OCT). J Drugs Dermatol. 2016 May;15(5):611-616.

Markowitz O., Schwartz M., Minhas S., Siegel DM. Speckle-Variance Optical Coherence Tomography: A Novel Approach to Skin Cancer Characterization Using Vascular Patterns. Dermatology Online Journal. 2016 Apr; 22 (4): 1-6.

Markowitz O., Schwartz M., Feldman E., Bienenfeld A., Bieber AK., Ellis J., Alapati U., Lebwohl M., Siegel DM. Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy. JCAD. 2015 October;8(10): 14-20.

Luber AJ., Bienenfeld AR., Clark CM., Markowitz O. Characterization of knuckle (Garrod pads using optical coherence tomography in vivo. CUTIS. 2015 September;96 (3): E10-1

Markowitz O., Utz S. Differentiating Early Stage Cystic Keratoacanthoma, Nodular Basal Cell Carcinoma and Excoriated Acne Vulgaris by Clinical Exam, Dermoscopy and Optical Coherence Tomography: A Report of Three Cases. JCAD. 2015 April; 8(4): 48-50.

Williams EL., Derek Ho MK., Halpern AC., Markowitz O., Siegel DM. Relationship between melanoma detection pattern and tumor thickness. Am J Prev Med. 2014 Oct; 47(4):411-6.

Urban J., Siripunvarapon AH., Meekings A., Kalowitz A., Markowitz O. Optical coherence tomography imaging of erythromatotelangiectatic rosacea during treatment with bromidine topical gel 0.33%: a potential method for outcome assessment. J Drugs Dermatol. 2014 Jul;13(7):821-6.

Wang KX., Meekings A., Fluhr JW., McKenzie G., Lee DA., Fisher J., Markowitz O., Siegel DM. “Optical coherence tomography-based optimization of mohs micrographic surgery of Basal cell carcinoma: a pilot study” Dermatol Surg. 2013 Apr;39(4):627-33.

Hui AM., Jacobson M., Markowitz O., Brooks NA., Siegel D. “Mohs Micrographic Surgery for the Treatment of Melanoma.”. Dermatol Clin. June 2012

Lee J., Jorizzo J., Lebwohl M., Markowitz O., Levy S. “Cryosurgery followed by imiquimod 3.75% to treat actinic keratosis.” J Am Acad Dermatol. 64 (Issue 2, Supp 1):AB2. 2011

Emer JJ., Stevenson ML., Markowitz O. “Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.” J Drugs Dermatol. 2011 Jul;10(7): 795-8.

Emer J., Markowitz O. “Trends in the treatment and detection of skin cancer.” J Drugs Dermatol. 2011 Jan;10(1):16-8.

Jorizzo J., Markowitz O., Lebwohl M., Bourcier M., Kupl J., Meng T, and Levy S. “Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of 3.75% Imiquimod Cream Following Cryosurgery for the Treatment of Actinic Keratoses,” Randomized; J Drugs Dermatol 9 (Issue 9): 2010.

Feldman S., Wyres M., Markowitz O., Matheson R., Bruce S. “Calcipotriene foam for the treatment of plaque-type psoriasis: Results of two phase III studies,”; J Am Acad Dermatoly 62 (Issue 3, p 1): 2010.

Markowitz O., Lowenstein E. Anhydrotic ectodermal dysplasia: A case report and discussion of the literature. J Am Acad Dermatol 2007; 56 (Issue 2, Supp 2):AB112.

Markowitz O., Uliasz A. Pseudoxanthoma elasticum–like papillary dermal elastolysis: A case report J Am Acad Dermatol 2009; 60 (Issue 3, Supplement 1): AB64.

BOOKS

Markowitz O. A practical guide to dermoscopy. Philadelphia: Wolters Kluwer (2017).ISBN-13: 978-1451192636


CHAPTERS

Hui A., Philip Friedlaner, Markowitz O.; “ Treatment of Skin Disease: 4th Edition,” Chapter 10:

Malignant Melanoma, Publication 2013.

Yoo JY, Al Naami M., Markowitz O. and Hadi SM. “Allergic contact dermatitis: patch testing

results at Mount Sinai Medical Center.” Skinmed Sep-Oct;8(5):25760. 2010

Nazarian, R., Markowitz, O. “Buka's Emergencies in Dermatology,” Chapter 12: Child Abuse, Publication 2013.

Markowitz O., Rigel D; “Treatment of Skin Disease: 3rd Edition,” Chapter 10: Malignant Melanoma, Publication 2009.

 

PUBLICATIONS POSTERS 

Markowitz O, Wang K, Levine A, Schwartz M, Minhas S, Feldman E, Siegel D. Defining field cancerization of the skin using non-invasive optical coherence tomography imaging to detect and monitor actinic keratosis in ingenol mebutate 0.015%-treated patients--The extension study. Presented at the 2017 Maui Derm for Dermatologists Conference. March 20-24th, 2017. Maui, Hawaii.

Schwartz M., Levine A., Wang K., Markowitz O. Dermoscopy of a Hypomelanotic Melanoma Masquerading as a Squamous Cell Carcinoma. Pigment Cell and Melanoma Research Journal. 2016, Aug; Pub Status: Accepted.

E. Feldman, T. Cao, D. M. Siegel, O. Markowitz; Confocal Microscopy: A Case Differentiating

Lichen Planus-Like Keratosis(LPLK) from Lentigo Maligna Melanoma in Situ (MMIS) on the

Face.” American Academy of Dermatology 2015.

 

Markowitz O., Feldman E., Schwartz M. Kalowitz A., Bienenfeld, A. and Siegel, M.; “Field

Cancerization using OCT & RCM pre- and post- treatment with ingenol Mebutate 0.015% gel.”

Fall and Winter Clinical Dermatology, 2014.

 

Aref, A, Dela Cruz, A. Kalowitz, A. Etan, Beaudett. Markowitz, O. “Optical Coherence

Tomography Atlas: OCT Image Atlas” European Academy of Dermatology; Summer and Winter Meetings, 2013

 

Markowitz, O., Nandanan, N., Fisher, J.,Fisher, J., Jacobson, and M. Siegel,D.; “Differentiating

Cystic Keratoacanthoma, Basal Skin Cancer and Excoriated Acne Vulgaris using Optical Coherence Tomography (OCT) and Dermoscopy: Case Series. European Academy of Dermatology; Summer 2014.

 

Amy Kalowitz, BS; Arunee Siripunvarapon, MD; Orit Markowitz, MD “The use of optical

coherence tomography (OCT) as an alternative to diagnostic biopsies prior to Mohs surgery to

improve cosmetic outcomes in patients with non-melanoma skin cancers: A pilot study” Mount

Sinai Innovations, 2013.

 

Nandanan, N., Fisher, J.,Siegel,D. and Markowitz, O. “Optical Coherence Tomography Imaging

of Onychomycosis” European Academy of Dermatology; Summer Meeting: poster presentation

2012.

 

Majdy Albahhar MD, Juliya Fisher, and Orit Markowitz MD “A case of Disseminated

Superficial Actinic Porokeratosis (DSAP) successfully treated with a combination topical

therapy” American Academy of Dermatology; Summer Meeting, 2011.

 

PRESENTATIONS

Meet the experts: One treatment, no cutting noninvasive diagnosis and laser management of skin cancer; American Academy of Dermatology Conference, March 2019

 

United Dermoscopy cases. American Academy of Dermatology, March 2019

 

Combining imaging with laser treatment for skin cancer; Sciton User Summit, Fall 2018

 

Course Director: Reflectance Confocal Microscopy Course, World Congress of Confocal Microscopy, Rome, October 2018

 

Course Director: Optical Coherence Tomography Course, World Congress of the International Dermoscopy Society, Greece, June 2018

 

Combining imaging with laser treatment for skin cancer; American Society for Laser Medicine and Surgery, April 2018

 

Symposium Co-chair: 2017 Mount Sinai Fall Symposium: Innovations in Aesthetic, Medical and Diagnostic Dermatology, New York, NY, September 23rd – 25th.

 

Expert Speaker: American Society for Dermatologic Surgery (ASDS) Annual Meeting, New Orleans, November 2016.

 

Expert Speaker: Fall Clinical Dermatology Conference, Las Vegas, October 2016.

 

Course Director: Advanced Dermoscopy Course, American Academy of Dermatology, March

2016, 2017

 

Forum Director: Optical Coherence Tomography; American Academy of Dermatology, March

2017, ‘16, ‘15,’14,’13

 

The Greater New York Dermoscopy Course: A full day dermoscopy training for NY and NJ

Dermatology Residents, January 2017, ‘16, ‘15,’14,’13

 

Confocal Microscopy Symposium: US Cases; American Academy of Dermatology March 2015,

’14’13

 

Melanoma Symposium: Dermoscopy & New Diagnostic Technologies; American Academy of

Dermatology 2015

 

Workshop: Dermoscopy Pearls; Hawaii Dermatology Winter Clinical January 2015,’13

Field Cancerization pre and post Ingenol mebutate 0.015% gel application; Las Vegas Fall

Clinical Dermatology, October 2014

 

Director: Office Emergencies Symposium, Mount Sinai Winter Symposium December 2012,

‘11, ‘10, ‘09, ‘08

 

Basic Melanocytic Dermoscopy and Dermatopathology Correlates: Mount Sinai Winter

Symposium, December 2014, ’13’12, ’11, ’10, ’09, ’08

 

Basic Melanocytic Dermoscopy and Dermatopathologic Correlates; North Carolina Dermatology

Association Meeting, January 2011

 

New Innovation in the Treatment of Skin Cancer and Actinic Keratoses; The Greater NY

Dermatology Society at Lenox Hill, September 2009

 

Plenary Session: Dermatology Treatment: Treatment of Skin Cancer; American Academy of

Dermatology, March 2009

 

Focus Session: Basic Melanocytic Dermoscopy; American Academy of Dermatology, March

2009